These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 6553451

  • 1. Penicillin sensitive nutritionally variant streptococcal endocarditis: relapse after penicillin therapy.
    Levine JF, Hanna BA, Pollock AA, Simberkoff MS, Rahal JJ.
    Am J Med Sci; 1983; 286(1):31-6. PubMed ID: 6553451
    [Abstract] [Full Text] [Related]

  • 2. Penicillin combined with gentamicin or streptomycin: synergism against enterococci.
    Watanakunakorn C.
    J Infect Dis; 1971 Dec; 124(6):581-6. PubMed ID: 5209849
    [No Abstract] [Full Text] [Related]

  • 3. Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis.
    Parrillo JE, Borst GC, Mazur MH, Iannini P, Klempner MS, Moellering RC, Anderson SE.
    N Engl J Med; 1979 Feb 08; 300(6):296-300. PubMed ID: 252640
    [No Abstract] [Full Text] [Related]

  • 4. Endocarditis caused by nutritionally-variant streptococci: therapy with penicillin combined initially with gentamicin.
    Dworzack DL, Clark RB, Pugsley MP, Stanosheck JF, Dehning MM.
    Nebr Med J; 1986 May 08; 71(5):118-21. PubMed ID: 3713907
    [No Abstract] [Full Text] [Related]

  • 5. A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis.
    Moellering RC, Murray BE, Schoenbaum SC, Adler J, Wennersten CB.
    J Infect Dis; 1980 Jan 08; 141(1):81-6. PubMed ID: 6767791
    [Abstract] [Full Text] [Related]

  • 6. Tricuspid valve endocarditis due to a moderately susceptible Streptococcus constellatus: persistent bacteremia and fatal outcome despite penicillin plus gentamicin therapy.
    Baran J, Abdo WM, Merritt KW, Khatib R.
    Scand J Infect Dis; 1998 Jan 08; 30(4):420-1. PubMed ID: 9817527
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic susceptibility of streptococci and related genera causing endocarditis: analysis of UK reference laboratory referrals, January 1996 to March 2000.
    Johnson AP, Warner M, Broughton K, James D, Efsratiou A, George RC, Livermore DM.
    BMJ; 2001 Feb 17; 322(7283):395-6. PubMed ID: 11179156
    [No Abstract] [Full Text] [Related]

  • 8. Antibiotic synergism against group D streptococci in the treatment of endocarditis.
    Ruhen RW, Darrell JH.
    Med J Aust; 1973 Jul 21; 2(3):114-6. PubMed ID: 4490252
    [No Abstract] [Full Text] [Related]

  • 9. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
    Gavaldà J, Pahissa A, Almirante B, Laguarda M, Crespo E, Pou L, Fernández F.
    Antimicrob Agents Chemother; 1995 Sep 21; 39(9):2098-103. PubMed ID: 8540723
    [Abstract] [Full Text] [Related]

  • 10. Treatment of endocarditis caused by relatively resistant nonenterococcal streptococci: is penicillin enough?
    DiNubile MJ.
    Rev Infect Dis; 1990 Sep 21; 12(1):112-7. PubMed ID: 2405464
    [Abstract] [Full Text] [Related]

  • 11. Synergy of penicillin and gentamicin against Enterococci.
    Moellering RC, Wennersten C, Weinberg AN.
    J Infect Dis; 1971 Dec 21; 124 Suppl():S207-9. PubMed ID: 5209574
    [No Abstract] [Full Text] [Related]

  • 12. Streptococcus milleri endocarditis complicated by myocardial abscess.
    Levandowski RA.
    South Med J; 1985 Jul 21; 78(7):892-3. PubMed ID: 4012392
    [Abstract] [Full Text] [Related]

  • 13. Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.
    Bouvet A, Cremieux AC, Contrepois A, Vallois JM, Lamesch C, Carbon C.
    Antimicrob Agents Chemother; 1985 Nov 21; 28(5):607-11. PubMed ID: 4091526
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial therapy of streptococcal endocarditis.
    Wilson WR.
    J Antimicrob Chemother; 1987 Sep 21; 20 Suppl A():147-59. PubMed ID: 3316158
    [Abstract] [Full Text] [Related]

  • 15. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.
    Saleh-Mghir A, Cremieux AC, Vallois JM, Muffat-Joly M, Devine C, Carbon C.
    Antimicrob Agents Chemother; 1992 Nov 21; 36(11):2403-7. PubMed ID: 1489184
    [Abstract] [Full Text] [Related]

  • 16. Penicillin-netilmicin synergism against Streptococcus faecalis.
    Korzeniowski OM, Wennersten C, Moellering RC, Sande MA.
    Antimicrob Agents Chemother; 1978 Mar 21; 13(3):430-4. PubMed ID: 122522
    [Abstract] [Full Text] [Related]

  • 17. Penicillin-sensitive streptococcal endocarditis. In-vitro and clinical observations on penicillin-streptomycin therapy.
    Wolfe JC, Johnson WD.
    Ann Intern Med; 1974 Aug 21; 81(2):178-81. PubMed ID: 4843573
    [No Abstract] [Full Text] [Related]

  • 18. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT, Pelletier LL, Petersdorf RG.
    J Clin Invest; 1974 Mar 21; 53(3):829-33. PubMed ID: 4492776
    [Abstract] [Full Text] [Related]

  • 19. The ineffectiveness of tobramycin combination therapy in Streptococcus faecium endocarditis.
    Goldstein JA, Cohen H, Bia FJ.
    Yale J Biol Med; 1983 Mar 21; 56(3):243-9. PubMed ID: 6659563
    [Abstract] [Full Text] [Related]

  • 20. High-level aminoglycoside resistance mediated by aminoglycoside-modifying enzymes among viridans streptococci: implications for the therapy for endocarditis.
    Farber BF, Yee Y.
    J Infect Dis; 1987 May 21; 155(5):948-53. PubMed ID: 3644853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.